Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas

Clinical trial NCT00877214 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00877214
Sponsor: Jurgen Barth
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Follicular Lymphomas Immunocytomas Marginal Zone Lymphomas Mantle-Cell Lymphomas Lymphocytic Lymphoma Non-Hodgkin's Lymphoma

Start date: 2009-04-01
Primary completion: 2024-12-01
Enrollment: 1272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.